Prostatis Group’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
VCM
VPM
Prostatis Group's JNJ Position: Q1 2026 in Review
Prostatis Group increased its Johnson & Johnson (JNJ) stake by 1.6% in Q1 2026, buying an estimated $10.5K and bringing the position to 2,808 shares worth $686K. The position accounts for 0.18% of the portfolio, ranked #91.
Prostatis Group first reported a position in JNJ in Q4 2019 and has held it in 20 quarters since. The position peaked at $1.05M in Q4 2022. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Prostatis Group held 2,808 shares of Johnson & Johnson worth $686K as of Q1 2026.
- Prostatis Group bought 45 Johnson & Johnson shares in Q1 2026, an estimated $10.5K.
- Johnson & Johnson made up 0.18% of Prostatis Group's portfolio in Q1 2026, its #91 holding.
- Prostatis Group first reported a position in Johnson & Johnson in Q4 2019 and has held it in 20 quarters since.
- Prostatis Group's Johnson & Johnson position peaked at $1.05M in Q4 2022.
- 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.